XPRIZE Healthspan Names Top Teams Including Armatus Bio, Immunis for $101 Million Prize to Extend Healthy Aging

The XPRIZE Healthspan competition, a seven-year initiative with a $101 million prize, aims to develop groundbreaking methods to dramatically rejuvenate human muscles, cognition, and immune functions, thereby extending healthy aging. The competition has named its top 100 teams advancing healthy aging, including finalists and semifinalists such as Armatus Bio, Immunis, and a collaborative team involving the Buck Institute and the University of Toulouse. The prize is the largest longevity-focused award to date and seeks to accelerate progress in combating chronic ailments associated with aging. Companies like HAYA Therapeutics are leveraging novel approaches such as the 'dark genome' to tackle age-related diseases, while NewLimit recently raised $130 million in a Series B funding round to advance epigenetic reprogramming technologies aimed at improving cell function and longevity. The initiative highlights the growing momentum in the longevity research field and the pursuit of interventions that improve intrinsic capacity without relying solely on drugs.